Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Posner

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Gene Therapy|February 7, 2003
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma modelV K Gupta, J O Park, T Kurihara, et al.
Cancer|July 9, 1998
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinomaU Ribeiro, S D Finkelstein, A V Safatle-Ribeiro, et al.
Surgery|October 3, 2000
Hepatic resection: effective treatment for primary and secondary tumorsJ F Buell, S Rosen, A Yoshida, et al.
British Journal of Cancer|June 5, 2015
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcomeS C Wightman, A Uppal, S P Pitroda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2010
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031V J Picozzi, R A Abrams, P A Decker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium studyS Mani, J W Kugler, D F Sciortino, et al.
Cancer Gene Therapy|November 1, 2008
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapyH J Mauceri, M A Beckett, H Liang, et al.
Cancer Research|January 13, 2001
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicityR M Salloum, N T Jaskowiak, H J Mauceri, et al.
Scientific Reports|October 25, 2016
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder CancersK B Skowron, S P Pitroda, J P Namm, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Gene Therapy|February 7, 2003
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma modelV K Gupta, J O Park, T Kurihara, et al.
Cancer|July 9, 1998
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinomaU Ribeiro, S D Finkelstein, A V Safatle-Ribeiro, et al.
Surgery|October 3, 2000
Hepatic resection: effective treatment for primary and secondary tumorsJ F Buell, S Rosen, A Yoshida, et al.
British Journal of Cancer|June 5, 2015
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcomeS C Wightman, A Uppal, S P Pitroda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2010
Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031V J Picozzi, R A Abrams, P A Decker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium studyS Mani, J W Kugler, D F Sciortino, et al.
Cancer Gene Therapy|November 1, 2008
Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapyH J Mauceri, M A Beckett, H Liang, et al.
Cancer Research|January 13, 2001
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicityR M Salloum, N T Jaskowiak, H J Mauceri, et al.
Scientific Reports|October 25, 2016
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder CancersK B Skowron, S P Pitroda, J P Namm, et al.
Pageof 5